Haijun Zhong

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study

Wei Li, F. Gao, Y. Ba, 2023, BMC Medicine.